Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Peripheral T-Cell Lymphoma (PTCL)
  • Types of Peripheral T-Cell Lymphoma
  • Current Standard of Care
  • New & Emerging Treatment Approaches
  • Treatments Under Investigation
  • Updates on Clinical Trials
  • How Clinical Trials Contribute to Your Treatment Options
  • Practical Tips to Manage Treatment Side Effects, Symptoms & Discomfort
  • Follow-Up Care
  • Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions and Discussion of OpenNotes
  • Key Questions to Ask Your Health Care Team
  • Communicating with Your Health Care Team about Your Quality-of-Life Concerns & Follow-Up Appointments
  • Questions for Our Panel of Experts

Our Panel of Experts


Alison J. Moskowitz, MD

Associate Professor of Medicine, Weill Cornell Medical College, Lymphoma Specialist, Associate Attending, Clinical Director of the Lymphoma Service, Memorial Sloan Kettering Cancer Center


Neha Mehta-Shah, MD, MSCI

Associate Professor, Department of Medicine, Oncology Division, Medical Oncology, Department of Medicine, Divisions of Hematology & Oncology, Washington School of Medicine in St. Louis


Nora Bennani, MD

Assistant Professor of Medicine, Clinical Cell Therapy Fellowship Program Director, T-cell Lymphoma Research Program Director, Mayo Clinic College Of Medicine


Robert P. Goldman, JD, LLM

Director, Lymphoma Foundation of America®


Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare


You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on August 23, 2023.

Search by:



The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.